← Back to headlines
Ugandan Company Secures Seven US Patents for mRNA Cancer Vaccine
A biotech firm based in Uganda has successfully filed multiple patents in the United States for a novel mRNA-based therapeutic targeting cancer, marking a significant milestone in African pharmaceutical innovation.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
